The Evolutionary Model of Mild-to-moderate Myopia in China
1 other identifier
observational
852,441
1 country
1
Brief Summary
Myopia has emerged as a major health issue in east Asia, because of its increasingly high prevalence in the past few decades (now 80-90% in school-leavers), and because of the sight-threatening pathologies associated with high myopia, which now aff ects 10-20% of those completing secondary schooling in this part of the world. Similar, but less marked, changes are occurring in other parts of the world. The higher prevalence of myopia in east Asian cities seems to be associated with increasing educational pressures, combined with life-style changes, which have reduced the time children spend outside.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 24, 2016
CompletedFirst Posted
Study publicly available on registry
January 29, 2016
CompletedApril 14, 2016
April 1, 2016
10.8 years
January 24, 2016
April 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Refractive error of both eyes measured by autorefractor and subjective measuring
Baseline
Eligibility Criteria
Subjects from all the province of China who undergoing the examination of Refractive error from 2005 to 2015 year.
You may qualify if:
- Patients complete the examination of Refractive error from 2005 to 2015 year.
You may not qualify if:
- Patients could not complete the examination of Refractive error
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sun Yat-sen Universitylead
- Ministry of Health, Chinacollaborator
Study Sites (1)
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
Related Publications (1)
Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012 May 5;379(9827):1739-48. doi: 10.1016/S0140-6736(12)60272-4.
PMID: 22559900BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Haotian Lin Lin, M.D., Ph.D
Zhongshan Ophthalmic Center, Sun Yat-sen University
- STUDY CHAIR
Yizhi Liu, M.D., Ph.D
Zhongshan Ophthalmic Center, Sun Yat-sen University
- PRINCIPAL INVESTIGATOR
Erping Long, M.D., Ph.D
Zhongshan Ophthalmic Center, Sun Yat-sen University
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Home for Cataract Children, Zhongshan Ophthalmic Center
Study Record Dates
First Submitted
January 24, 2016
First Posted
January 29, 2016
Study Start
January 1, 2005
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
April 14, 2016
Record last verified: 2016-04